ag 112 has been researched along with go 6976 in 1 studies
| Studies (ag 112) | Trials (ag 112) | Recent Studies (post-2010) (ag 112) | Studies (go 6976) | Trials (go 6976) | Recent Studies (post-2010) (go 6976) |
|---|---|---|---|---|---|
| 19 | 0 | 10 | 504 | 1 | 133 |
| Protein | Taxonomy | ag 112 (IC50) | go 6976 (IC50) |
|---|---|---|---|
| Protein kinase C gamma type | Homo sapiens (human) | 0.002 | |
| Protein kinase C beta type | Homo sapiens (human) | 0.0041 | |
| Protein kinase C alpha type | Homo sapiens (human) | 0.0027 | |
| Protein kinase C delta type | Homo sapiens (human) | 0.446 | |
| Serine/threonine-protein kinase D1 | Homo sapiens (human) | 0.0445 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
1 other study(ies) available for ag 112 and go 6976
| Article | Year |
|---|---|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |